Top 5 Stock Picks of Paul Marshall and Ian Wace’s Marshall Wace LLP

Page 5 of 5

1. Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)

Paul Marshall and Ian Wace’s Marshall Wace LLP’s Stake Value: $377,583,000

Percentage of Paul Marshall and Ian Wace’s Marshall Wace LLP’s 13F Portfolio: 1.56%

Number of Hedge Funds: 33

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) is the New Haven, Connecticut-based biopharmaceutical corporation behind Rimegepant. The breakthrough therapeutic aids in the acute treatment of migraine and received FDA approval. The company is also working on developing the drug as a preventive treatment for migraine. Paul Marshall and Ian Wace’s Marshall Wace LLP initiated a significant position of over 2.5 million shares in Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) in the third quarter of 2020.

On December 6, Christopher Raymond at Piper Sandler issued an Overweight rating on Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) stock with a price target of $156.

You can also take a peek at the 10 Best Big Pharma Stocks to Buy Now and 11 Best Auto Stocks To Invest In.

Page 5 of 5